1/22
Looks like no tags are added yet.
Chemical external factors
Benzene → leukemia
Asbestos → lung cancer
Beetle nut → oral cancer
Tobacco → Lung, kidney, bladder cancers
Viral external factors
Epstein-Barr → burkett’s lymphoma
HIV → Kapsi’s sarcoma
HPV → cervical cancer
Internal factors
Immune conditions → lymphoma
Hormones → breast
Inherited mutations → breast, colon, retinoblastoma
Tumor induction & development
Chemical, Radiation, Physical, Viral
Method/Sites cancer can arise
application → skin
Breakdown → liver
Absorption → intestine
Secretion → kidney & bladder
Unexpected
DES passed to offspring → neu oncogene
DES given → ras oncogene
4 stages of Carcinogenesis
Initiation → mutagenic initiator that alters genetic information (DNA, RNA, protein)
Only chemicals are considered initiators
Irreversible
Promotion → clonal expansion of initiated cells
Not carcinogenic
Reversible
Activate protein kinases
Ex. TPA & PMA
Malignant conversion → cells change to malignant phenotype
Genetic changes → increase oncogenes, decrease timor suppressor genes, acquired aggressive behavior
If not change occurs, cell can revert back to initiated cells
Tumor progression → malignant tumor cells invade and damage host cells
Clinical symptoms appear
UV light
melanoma → rays penetrate deeper into skin
Usually causes basal cell carcinoma
Slow growing cancer can be removed
Made of A, B, C rays
Radioactive carcinogens
α, β, γ, and X-rays
Physical stage → H2O loses electron
Chemical stage → free electron interacts with other molecules to produce free radicals → interacts w/ DNA & damage cell
Cellular stage → growth & division of cells
Cancer progression stage → spread can take hours/months/years/latent
Xeroderma pigmentosa
highly sensitive to live → changes in skin, eyes, & neurological problems
30-40yr reduced life-span from defect in DNA excision repair
Squamous/Basal cell carcinoma, Melanoma

Chemotherapeutic regimens
highest tolerable dose
High dose Intermittent > daily low doses
Non-specific → dmg to bone marrow, gonads, oral mucosa, hair follicles
Adjuvant chemotherapy
given after surgery
Radiation treatment of micro-metastasis & tumor remnants
Large tumors with small burden
For recurrent cancer risks
Neo-adjuvant chemotherapy
Treatment to reduce the tumor mass prior to surgery & radiation
Treat metastasis
Palliative therapy
alleviate symptoms
Advanced stage cancers
Supportive therapy
Treatment with antibiotics during chemotherapy
Infection from suppressed immune system
Polychemotherapy
treatment with several drugs given consecutively or simultaneously
can target multiple cell cycle phases
Initial letter designations
TNM system
T → extent of primary tumor, size, regional involvement
0: not seen
1: < 3cm
2: > 3cm
N → lymph node involvement
0: none
1: involved 2-3 positive lymph nodes
2: involved 3-5
M → metastasis
0: absence, 1: present
Clinical → before treatment
Pathological → after surgery/biopsy
Recurrent or Re-treatment → classification after reoccurrence/therapy
Autopsy → classification after death
Cell cycle
Diving cell phases
G1 → Pre-synaptic; before DNA synthesis; determines cycle length
S → “Synthetic;” DNA & histone protein synthesis; chromosome replication
G2 → Post-synaptic; nucleus organization for mitosis; doubled in DNA
Interphase → G1-S-G2 phases
M → mitosis; 1-2 hrs
Non-dividing: G0
shorter cell cycles in tumor cells
Year long division → neurons, skeletal, liver
Hourly division → GI, bone marrow
Cyclin proteins
binds to cyclin dependent kinases (CKD)
Cyclin A, B, D, E
Cell kill hypothesis
ability of drugs to kill a constant percentage of tumor cells
Growth fraction
percentage of tumor cells dividing
Chemotherapy cannot attack non-dividing cells
Tumors are heterogenous mass of cells
Determined by mitotic labeling index
Tumor mass doubling
depends on the number of dividing cells
Counts only if growth fraction is 100%
Tumor experiences plateau in growth over time
Tumor growth factors
relationship between tumor size, cell cycles doubling, and growth fraction
Growth factor decreases over time But tumor size increases
Classification of chemotherapy
historically by sensitivity
1-4 positive response
cell cycles specific
MOA
Alkylating agents
Antimetabolites
Natural compounds
Topoisomerase inhibitors
Abs
Kinase inhibitors
Anti-hormonal drugs